Roxanne Ferdinand

Dr Roxanne Ferdinand is Vice President, Global Medical Franchise Lead for Genitourinary (GU) Cancers at Pfizer Oncology where she is responsible for developing and implementing the global medical strategy including data generation, medical education and partnerships with healthcare professionals and patient advocates, in order to speed breakthrough medicines to patients with kidney, bladder and prostate cancer. Prior to joining Pfizer, she worked in the UK National Health Service as a Hematologist at St Bart’s and the Royal London Hospital. Roxanne earned her MD at Imperial College London (2004) as well as her BSc in Pharmacology & Toxicology (2002) and is a member of the Royal College of Physicians (MRCP) and the Faculty of Pharmaceutical Medicine (MFPM).